• Invst Guru
  • Posts
  • 🚀 Unveiling This Week's Crowdfunding Campaigns: Releases, Trends, and Final Opportunities!

🚀 Unveiling This Week's Crowdfunding Campaigns: Releases, Trends, and Final Opportunities!

Explore Our Newest Selections: 2 Recent Releases, 2 Trending Must-Haves, 2 Last Opportunities, and a Featured Deal You Won't Want to Overlook!

invstguru | The guru is in.

Crowdfunding Has Never Been This Easy

Weekly newsletter about the latest news, updates, and information about crowdfunding campaigns.

Just Launched Campaigns

OptiPulse

OptiPulse Inc on Netcapital

OptiPulse Inc. is a company featured on NetCapital, focusing on the development of advanced 6G communications through optical wireless technology. Here's a summary of their offering:

Key Highlights

  1. Investment Attraction: Fyta has successfully raised $4,334,173 from 176 investors. Investment terms include future equity with a $21M valuation cap and various investor perks depending on the investment amount.

  2. Notable Investors and Endorsements: The company has attracted attention from notable investors like Mark Galvin, Kyle Vogt, Jesse Itzler, D. Scott Olivet, Javale McGee, Justin Kan, and Taylor Schupe. These investors commend Fyta for its potential to revolutionize the plant protein market.

  3. Product Excellence: Fyta's flagship product, Elite Plant Protein, is acclaimed for its superior taste and texture compared to other plant-based proteins. It even excels in taste tests against leading comparable products and is praised for its high digestibility.

  4. Sustainable and Quality Ingredients: The product is made from American non-GMO, upcycled barley, and is considered a highly sustainable protein source.

Misaa

Misaa on Netcapital

Misaa is a company featured on NetCapital, developing a 15-minute blood test for Tacrolimus, crucial for organ transplant patients. This innovative rapid test is designed for use in laboratories, point-of-care, and home settings, aiming to enhance transplant outcomes and benefit recipients, caregivers, and service providers. The company's campaign highlights a minimum investment of $99, with a deadline set for March 29, 2024.

Key Highlights

  1. Problem Addressed: Tacrolimus is a vital immunosuppressive drug for organ and tissue transplant patients. Current monitoring methods are painful, complex, and costly. Misaa aims to improve this with their rapid test.

  2. Solution Proposed: Developed by the seasoned scientists at IOS, the test is a patented (pending) Enhanced Lateral Flow Assay (ELFA) for quick and accurate monitoring of Tacrolimus levels in capillary blood from a fingerstick.

  3. Business Model: Misaa proposes a business model that includes the sale of test kits, reagents, and cloud-based monitoring services. The estimated pricing includes a $1,300 one-time purchase for the kit and reader, and approximately $25/month for resupply and monitoring.

  4. Team Expertise: Led by Dr. Reuben Sandler (CEO), with a strong background in mathematics, management consulting, and leadership in various industries, and supported by experts like Dr. Rahul Ganguli and Trong Nguyen, Ph.D.

Trending Campaigns

Winsantor

Winsantor on Wefunder

Winsantor is a biotech company currently featured on Wefunder, working on developing the first disease-modifying drug for regenerating peripheral nerves. This drug aims to address neuropathy, a condition causing loss of feeling often associated with diabetes, chemotherapy, or nervous system diseases. Here are the key points:


Key Highlights

  1. Fundraising and Investment Terms: Winsantor has raised $180,502 from 46 investors. They offer future equity with a $500M valuation cap, with a minimum investment of $1,000. There are also investor perks based on investment levels.

  2. Drug Development and Promise: The drug in development has already shown significant promise in FDA trials. It's a repurposed medication with an excellent safety profile, currently in the final phase (Phase 3) of clinical studies for diabetic peripheral neuropathy (DPN).

  3. Market Opportunity and Uniqueness: This medication addresses a significant global market opportunity, with few or no similar competitors. Winsantor's approach also includes transitioning the compound from tablet to topical form, which may open additional opportunities.

  4. Support and Validation: Winsantor's science has received over $40M in innovation grants and a licensing deal worth over $200M plus royalties. This support demonstrates the potential and validity of their approach.

Taste of Nature Inc

Taste of Nature Inc on PicMii

Taste of Nature has been established for 31 years, Taste of Nature has evolved from selling exclusively in movie theaters to being present in major retailers like Walmart, Blockbuster, and various grocery and convenience stores. It's renowned for its Cookie Dough Bites® and has expanded its presence to over 45 countries.

Key Highlights

  1. Product Portfolio: The company leads in niche candy categories like edible cookie dough, prepackaged cotton candy, and chocolate-covered gummy bears. Recent innovations include Mars-branded poppable cookie dough snacks and spoonable cookie dough snacks in collaboration with brands like M&M's, Twix, and Snickers.

  2. Financial Highlights: For FY 2023, the company is projecting over $40M in revenue, marking a 35% growth over the previous year. They also plan to issue a one-time dividend to shareholders by the end of FY 2023.

  3. Growth Strategy and Market Positioning: The company has secured a licensing deal with Mars-Wrigley, creating new products like Skittles and Starburst cotton candies. They aim to grow from ~$30M in annual revenue (2022) to $70M+ by 2026.

  4. Distribution Channels: Taste of Nature is adapting to changes in the market, including a resurgence in theater sales post-COVID, and expanding its online presence through partnerships with Amazon distributors.

GACW

GACW on Dealmaker

Global Air Cylinder Wheels (GACW) presents an innovative tire technology, the Air Suspension Wheel (ASW), which has been recognized as one of Time Magazine's Best Sustainability Inventions of 2023. Here's a summary of key aspects from their webpage:


Key Highlights

  1. Innovation and Recognition: The ASW is an all-steel, 100% recyclable wheel, scalable for use in various sectors like automotive and construction. It's noted for its sustainability, safety, and performance advantages over traditional rubber tires.

  2. Market Potential and Business Model: GACW targets a vast potential market, with the global tire market projected to be over $504 billion. They have already generated over $3 million in sales and hold 37 patents, with more pending.

  3. Environmental and Economic Benefits: The ASW addresses significant environmental concerns posed by rubber tires, such as pollution and microplastic waste. Its durability and recyclability offer cost savings and reduced maintenance for industries.

  4. Company Roadmap and Strategy: GACW plans to expand its market reach, with ongoing trials in the mining industry and potential applications in other sectors like trucking and public transportation.

Curtiss Motorcycle

Curtiss Motorcycle on Wefunder

Curtiss Motorcycle Co. is a promising investment in the future of American motorcycle leadership. They have raised $115,960 from 56 investors with a minimum investment of $1,000. The company's focus is on luxury, sustainable two-wheeled motoring, and they are positioned as a competitor to Livewire, another exclusively electric American OEM.

Key Highlights

  1. Market Strategy: Their market strategy involves building the most desirable brand, aiming for a significant market valuation comparable to Livewire's over $2 billion.

  2. Exit Strategy: Curtiss plans for either a strategic M&A partnership in 2024 or an IPO around 2025-2026.

  3. Leadership: The team is led by H. Matthew Chambers (Co-founder, CEO, Chairman of the Board) and includes Jordan Cornille (Co-founder, Strategy Design) and JT Nesbitt (Head of Innovation + Design).

  4. Investor Endorsements: Prominent investors like James Hoegh and Whoopi Goldberg have invested in Curtiss, emphasizing the unique design and riding experience offered by their motorcycles.

Spotlight Deal Review

Cardio.io on Wefunder

Card.io is a gamified fitness app that turns cardio exercises into a team turf war game. It has raised $64,951 from 64 investors on Wefunder, with a $5M valuation cap. The app has 10K users in over 500 cities and 65 countries. It integrates with Strava, Garmin, and Apple Health and has partnerships with various marathons and running clubs. It's advised by industry experts from companies like Strava, Pokemon Go, and Adidas. The app aims to make cardio engaging and fun, and has a strong focus on user experience and technology integration.

Card.io offers a promising investment opportunity in the fitness and wellness industry, showcasing strong growth potential and market expansion. The app has already secured $1M in total funding and term sheets, with $500K closed. It has partnerships with Oracle for corporate wellness and connections with various marathons and running clubs. The user base is widespread, covering over 500 cities in 65 countries, and it has generated $5K in revenue.

The technology used by Card.io integrates with popular health apps and has a high user engagement, indicated by a 4.8-star rating from 129 ratings and over 5.5K active users. Its use of gamification enhances user retention and gives it an edge in the fitness app market.

Card.io represents a promising investment opportunity for those interested in the intersection of technology and fitness. Its innovative approach to cardio workouts, strong market presence, and potential for scalability, coupled with a solid business model and experienced leadership, make it a compelling option for investors. The project's success and future expansion could yield significant returns, making it a noteworthy consideration for investment in the tech-fitness space.

What Kind of Crowdfunding Campaigns Do You Look for to Build Your Portfolio?

Login or Subscribe to participate in polls.